FDA applicant

Oncor, Inc.

Suite 131 decision1989–19890 recalls

FDA records 1 decision for Oncor, Inc. (Suite 13) in 1989: 1 original PMA approval. All are in product code MAM (Dna-Probe, B And T Lymphocyte). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, hematology panel, where it files most

How often FDA has decided Oncor, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Oncor, Inc. since 2007.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Oncor, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Oncor, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Oncor, Inc.

Which product codes does it file in?

What has FDA decided for it lately?